Aqua Bio Technology ASA (ABT.OL)
NOK 6.93
(0.0%)
NOK 6.93
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2021 | -19.11 Million NOK | -27.82% |
| 2020 | -14.95 Million NOK | -13.15% |
| 2019 | -13.21 Million NOK | 28.02% |
| 2018 | -18.36 Million NOK | -14.33% |
| 2017 | -16.05 Million NOK | -1198.27% |
| 2016 | 1.46 Million NOK | -91.62% |
| 2015 | 17.44 Million NOK | 1803.24% |
| 2014 | 916.8 Thousand NOK | -67.5% |
| 2013 | 2.82 Million NOK | 214.25% |
| 2012 | 897.58 Thousand NOK | 106.66% |
| 2011 | -13.47 Million NOK | 9.72% |
| 2010 | -14.92 Million NOK | -73.95% |
| 2009 | -8.57 Million NOK | 76.23% |
| 2008 | -36.08 Million NOK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2021 FY | -19.11 Million NOK | -27.82% |
| 2020 FY | -14.95 Million NOK | -13.15% |
| 2019 FY | -13.21 Million NOK | 28.02% |
| 2018 FY | -18.36 Million NOK | -14.33% |
| 2017 FY | -16.05 Million NOK | -1198.27% |
| 2016 FY | 1.46 Million NOK | -91.62% |
| 2016 Q1 | 3.39 Million NOK | -52.96% |
| 2016 Q2 | -668.74 Thousand NOK | -119.71% |
| 2016 Q3 | -5.11 Million NOK | -664.19% |
| 2016 Q4 | 3.79 Million NOK | 174.36% |
| 2015 FY | 17.44 Million NOK | 1803.24% |
| 2015 Q3 | 2.9 Million NOK | -10.46% |
| 2015 Q4 | 7.21 Million NOK | 148.46% |
| 2015 Q1 | 4.09 Million NOK | 359.6% |
| 2015 Q2 | 3.24 Million NOK | -20.83% |
| 2014 Q3 | 2.11 Million NOK | 224.13% |
| 2014 Q1 | -385.97 Thousand NOK | 81.24% |
| 2014 Q2 | -1.7 Million NOK | -342.19% |
| 2014 FY | 916.8 Thousand NOK | -67.5% |
| 2014 Q4 | 890.86 Thousand NOK | -57.95% |
| 2013 FY | 2.82 Million NOK | 214.25% |
| 2013 Q4 | -2.05 Million NOK | -424.67% |
| 2013 Q3 | 633.81 Thousand NOK | -59.1% |
| 2013 Q2 | 1.54 Million NOK | -42.49% |
| 2013 Q1 | 2.69 Million NOK | 200.81% |
| 2012 Q1 | 8.37 Million NOK | 275.0% |
| 2012 FY | 897.58 Thousand NOK | 106.66% |
| 2012 Q4 | -2.67 Million NOK | -404.98% |
| 2012 Q3 | -529.38 Thousand NOK | 87.62% |
| 2012 Q2 | -4.27 Million NOK | -151.06% |
| 2011 Q1 | -3.16 Million NOK | 55.38% |
| 2011 Q4 | -4.78 Million NOK | -143.52% |
| 2011 FY | -13.47 Million NOK | 9.72% |
| 2011 Q3 | -1.96 Million NOK | 44.64% |
| 2011 Q2 | -3.55 Million NOK | -12.09% |
| 2010 Q2 | -3.53 Million NOK | -52.5% |
| 2010 FY | -14.92 Million NOK | -73.95% |
| 2010 Q4 | -7.09 Million NOK | -220.52% |
| 2010 Q1 | -2.31 Million NOK | 0.0% |
| 2010 Q3 | -2.21 Million NOK | 37.29% |
| 2009 FY | -8.57 Million NOK | 76.23% |
| 2008 FY | -36.08 Million NOK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Arctic Bioscience AS | -45.51 Million NOK | 58.007% |
| ArcticZymes Technologies ASA | 19.42 Million NOK | 198.393% |
| BerGenBio ASA | -190.4 Million NOK | 89.962% |
| Hofseth BioCare ASA | -106.68 Million NOK | 82.085% |
| PCI Biotech Holding ASA | -20.31 Million NOK | 5.918% |
| Thor Medical ASA | -26.56 Million NOK | 28.042% |
| Ultimovacs ASA | -189.23 Million NOK | 89.9% |